Leukemia, Myelodysplasia, Transplantation
News
CHMP says ponatinib’s benefits outweigh risks
Credit: CDC The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted its final opinion on...
Conference Coverage
Cancer survivors face financial, work-related issues
chemotherapy Credit: Rhoda Baer Many US cancer survivors may be experiencing financial or work-related hardship, a new survey suggests. Twenty-...
News
Enzyme ‘switch’ is key to new treatment strategy for T-ALL
Credit: Thomas Semkow Blocking the action of an enzyme “switch” needed to activate tumor growth may be a practical strategy for treating T-cell...
News
Study reveals incidence of mutations linked to leukemia, lymphoma
The findings, based on blood samples from nearly 3000 patients, don’t necessarily mean that people with these mutations will develop leukemia or...
News
Ibrutinib gets EU approval for CLL, MCL
Credit: Steven Harbour The European Commission has granted marketing approval for the Bruton’s tyrosine kinase inhibitor ibrutinib (Imbruvica) in...
News
Blocking STAT3 in NK cells to fight leukemia
Credit: Bjorn Onfelt/Dan Davis Inhibiting STAT3 in natural killer (NK) cells can kill leukemia in two ways, according to research published in...
News
CTL019 induces remission in “incurable” ALL
Key clinical point: CTL019 (formerly known as CART19) induced remission in 27 of 30 (90%) children and adults with refractory or relapsed ALL...
News
CAR T cells can produce durable remissions
Credit: Penn Medicine In a small study, 90% of children and adults with relapsed or refractory acute lymphoblastic leukemia (ALL) achieved...
News
Amoeba could help fight cancers
Experiments in a soil-dwelling amoeba have provided insight that could help us treat cancers characterized by PTEN mutations, researchers have...
News
Study reveals potential strategy for treating leukemia
The protein kinases Cdk4 and Cdk6 may determine the incidence and aggressiveness of leukemia, according to preclinical research. The study showed...
News
CAR T cells serve as bridge to HSCT in ALL
Credit: Charles Haymond An anti-CD19 chimeric antigen receptor (CAR) T-cell therapy can elicit complete responses (CRs) in heavily pretreated...